Eudaimonia Asset Management »

Avita Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.6M 249k 14.61
2023-06-30 $3.0M 174k 17.01
2023-03-31 $884k 135k 6.53

More positions owned by Eudaimonia Asset Management

Powell Industries Common Stock (POWL)
Cymabay Therapeutics Common Stock
Aehr Test Systems Common Stock (AEHR)
MiMedx Group Common Stock (MDXG)
Hudson Technologies Common Stock (HDSN)
RxSight Common Stock (RXST)
Applied Optoelectronics Common Stock (AAOI)
Vivo Capital Common Stock (SLNO)
Gambling.com Group Common Stock (GAMB)
Limbach Holdings Common Stock (LMB)
Roivant Sciences Common Stock (IMVT)
Arlo Technologies Common Stock (ARLO)
PetIQ Common Stock (PETQ)
Newpark Resources Common Stock (NR)
Avita Medical Common Stock (RCEL)

View all positions for Eudaimonia Asset Management

Top funds holding Avita Therapeutics

Vanguard Group
AWM Investment Company
Bank of New York Mellon
Dimensional Fund Advisors
Soleus Capital Management
1492 Capital Management
Charles Schwab Investment Management
AQR Capital Management
D. E. Shaw & Co
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Two Sigma Advisers
Bank of America Corporation
Barclays
Rhumbline Advisers
Wellington Management Company

View all funds holding Avita Therapeutics